Aikido pharma announces publication of artificial intelligence-machine learning sponsored research program for pancreatic cancer

New york, dec. 9, 2020 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced the publication of positive results from its artificial intelligence/machine learning sponsored research program in the field of pancreatic cancer. pancreatic ductal...
DOMH Ratings Summary
DOMH Quant Ranking